Cargando…

Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema

Atopic eczema, also known as atopic dermatitis, is a frequent, highly pruritic, chronic skin disease, which is typically running in flares. The traditional treatment mainly consists of the reactive application of topical anti-inflammatory agents such as topical corticosteroids and topical calcineuri...

Descripción completa

Detalles Bibliográficos
Autores principales: Wollenberg, Andreas, Ehmann, Laura Maximiliane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Dermatological Association; The Korean Society for Investigative Dermatology 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412232/
https://www.ncbi.nlm.nih.gov/pubmed/22879707
http://dx.doi.org/10.5021/ad.2012.24.3.253
_version_ 1782239940676943872
author Wollenberg, Andreas
Ehmann, Laura Maximiliane
author_facet Wollenberg, Andreas
Ehmann, Laura Maximiliane
author_sort Wollenberg, Andreas
collection PubMed
description Atopic eczema, also known as atopic dermatitis, is a frequent, highly pruritic, chronic skin disease, which is typically running in flares. The traditional treatment mainly consists of the reactive application of topical anti-inflammatory agents such as topical corticosteroids and topical calcineurin inhibitors. The short term benefit of this approach is well known, but long term remission between flares is difficult to achieve. Therefore, innovative long-term treatment strategies targeting flare prevention and skin barrier stabilization are needed. We and others have shown that normal looking, non-lesional skin of atopic dermatitis patients is immunobiologially not normal but characterized by an invisible inflammation and barrier defect. This has led to the novel concept of proactive therapy, which is defined as long-term, low-dose intermittent application of anti-inflammatory therapy to the previously affected skin, together with an ongoing emollient treatment of unaffected skin. This review article describes the most important long-term treatment options for atopic dermatitis, which includes emollient therapy, the novel concept of proactive treatment, the different ultraviolet light modalities and a selection of systemic immunosuppressive drugs and biologics. Current trial data, licensed indications, off-label use and relevant side effects of the different treatment modalities are summarized.
format Online
Article
Text
id pubmed-3412232
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Korean Dermatological Association; The Korean Society for Investigative Dermatology
record_format MEDLINE/PubMed
spelling pubmed-34122322012-08-09 Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema Wollenberg, Andreas Ehmann, Laura Maximiliane Ann Dermatol Review Article Atopic eczema, also known as atopic dermatitis, is a frequent, highly pruritic, chronic skin disease, which is typically running in flares. The traditional treatment mainly consists of the reactive application of topical anti-inflammatory agents such as topical corticosteroids and topical calcineurin inhibitors. The short term benefit of this approach is well known, but long term remission between flares is difficult to achieve. Therefore, innovative long-term treatment strategies targeting flare prevention and skin barrier stabilization are needed. We and others have shown that normal looking, non-lesional skin of atopic dermatitis patients is immunobiologially not normal but characterized by an invisible inflammation and barrier defect. This has led to the novel concept of proactive therapy, which is defined as long-term, low-dose intermittent application of anti-inflammatory therapy to the previously affected skin, together with an ongoing emollient treatment of unaffected skin. This review article describes the most important long-term treatment options for atopic dermatitis, which includes emollient therapy, the novel concept of proactive treatment, the different ultraviolet light modalities and a selection of systemic immunosuppressive drugs and biologics. Current trial data, licensed indications, off-label use and relevant side effects of the different treatment modalities are summarized. Korean Dermatological Association; The Korean Society for Investigative Dermatology 2012-08 2012-07-25 /pmc/articles/PMC3412232/ /pubmed/22879707 http://dx.doi.org/10.5021/ad.2012.24.3.253 Text en Copyright © 2012 The Korean Dermatological Association and The Korean Society for Investigative Dermatology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Wollenberg, Andreas
Ehmann, Laura Maximiliane
Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema
title Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema
title_full Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema
title_fullStr Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema
title_full_unstemmed Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema
title_short Long Term Treatment Concepts and Proactive Therapy for Atopic Eczema
title_sort long term treatment concepts and proactive therapy for atopic eczema
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412232/
https://www.ncbi.nlm.nih.gov/pubmed/22879707
http://dx.doi.org/10.5021/ad.2012.24.3.253
work_keys_str_mv AT wollenbergandreas longtermtreatmentconceptsandproactivetherapyforatopiceczema
AT ehmannlauramaximiliane longtermtreatmentconceptsandproactivetherapyforatopiceczema